Skip to main content

If you are having trouble viewing this message, please click here.
To ensure consistent delivery, please be sure to add us to your address book or your safe senders list.

March  21, 2018
New Study Finds Intensive BP Treatment Risky for
Some Patients

An analysis suggests that strict adherence to recent SPRINT blood pressure guidelines might not be the best approach. Find out which patients benefit most from intensive treatment and which ones are more likely to be harmed than helped.
Acetaminophen Overdoses Rise Substantially During
Cold/Flu Season

With a fierce influenza season just now waning, pharmacists should sound the alarm: Be careful about overdosing on acetaminophen. A study found that the likeliest cause of overuse was unknowingly taking more than one OTC product containing the painkiller. Here is more information.
Cost Is Significant Factor in Cardiac Drug Prescriptions
and Adherence

With vouchers to pay for cardiac drugs, physicians were more likely to prescribe them, and
patients were more likely to take them, according to a presentation at a recent cardiology conference. While that was expected, find out what result puzzled researchers.
Efforts to Curtail Outpatient Antibiotic Prescribing Are
Falling Short

While inappropriate use of antibiotics has declined in hospitals, only slight change has been documented in prescriptions issued from outpatient settings. Find out the results of a new study looking at antibiotic prescribing rates and what the authors suggest needs to be done.
Connect With U.S. Pharmacist

U.S. Pharmacist Weekly News Update is a service of Jobson Medical Information LLC
the publisher of U.S. Pharmacist, 160 Chubb Avenue, Suite 304, Lyndhurst, NJ 07071.
To change your address, reply to this message and give us your old and new addresses.
Type "Change of Address: U.S. Pharmacist Case Study Challenge" in the subject line.
Click here if you do not want to receive future emails from U.S. Pharmacist Weekly News Update.

Comments

Popular posts from this blog

ADMELOG A NEW INSULIN  LISPRO OPTION A MEALTIME INSULIN highly similar to Humalog ® in structure, pharmacology, efficacy, safety, and dosing 1-4 FOR DETAILS, VISIT ADMELOGPRO.COM Indication for ADMELOG ® (insulin lispro injection) 100 Units/mL ADMELOG is a rapid-acting human insulin analog indicated to improve glycemic control in adults with type 2 diabetes and adults and children (3 years and older) with type 1 diabetes. Important Safety Information for ADMELOG ® (insulin lispro injection) 100 Units/mL CONTRAINDICATIONS ADMELOG is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro or to any of its excipients. WARNINGS AND PRECAUTIONS Insulin pens and needles must never be shared between patients, even if the needle ...
If you are having trouble viewing this message, please click here . To ensure consistent delivery, please be sure to add us to your address book or your safe senders list. March 14, 2018 Higher Steroids Don’t Prevent Asthma Flare-Ups in Mild/Moderate Pediatric Cases Increasing the dose of inhaled steroids in children with mild/moderate asthma doesn’t have the desired effect and could have unintended consequences, according to a new study.  Here’s why  pharmacists might want to raise a red flag with with too-frequent refills. ...
Recommend OneTouch ® meters with confidence. We’re here to help your patients by offering the lowest co-pay on the most health plans. ‡ * Covered: For most plans, products that are generally available and reimbursed. † Medical exception may apply. ‡ Some health plans may have more than one brand available at the lowest co-pay. The information provided is not a guarantee of coverage or payment. Actual benefits are determined by each plan in accordance with its respective policies and procedures. All trademarks are the property of their respective owners. © 2018 LifeScan, Inc.   NACO/OTB/1016/0468c...